Susquehanna International Group’s RxSight RXST Stock Holding History

Susquehanna International Group’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$118K	Buy	+19,200	New	+$159K	﹤0.01%	12225
2025 Q1	–	Sell	-6,400	Closed	-$220K	–	13316
2024 Q4	$220K	Sell	6,400 -10,200	-61%	-$460K	﹤0.01%	10507
2024 Q3	$821K	Buy	+16,600	New	+$850K	﹤0.01%	7290
2024 Q1	–	Sell	-13,800	Closed	-$556K	–	13188
2023 Q4	$556K	Buy	+13,800	New	+$405K	﹤0.01%	8390

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Susquehanna International Group's RXST Position: Q1 2026 in Review

Susquehanna International Group reduced its RxSight (RXST) stake by 14% in Q1 2026, selling an estimated $95.2K and leaving 70,293 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #10023.

Susquehanna International Group first reported a position in RXST in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.57M in Q2 2023. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Susquehanna International Group held 70,293 shares of RxSight worth $433K as of Q1 2026.
Susquehanna International Group sold 11,461 RxSight shares in Q1 2026, an estimated $95.2K.
RxSight made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10023 holding.
Susquehanna International Group first reported a position in RxSight in Q1 2022 and has held it in 14 quarters since.
Susquehanna International Group's RxSight position peaked at $1.57M in Q2 2023.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.